Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)

Clinical trial NCT04275323 · COMPLETED

Trial details

NCT number: NCT04275323
Sponsor: Beijing Northland Biotech. Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arterial Occlusive Disease Ischemia Ulcers Peripheral Vascular Disease

Start date: 2019-08-02
Primary completion: 2024-06-03
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.